Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Glutamine Entersoluble Capsules versus placebo for diarrhea-predominant irritable bowel syndrome
ISRCTN85973621Phase 2Completed
- Sponsor
- Chengdu Di'ao Pharmaceutical Group
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Compound Glutamine Entersoluble Capsules with Placebo (2 arms). Primary endpoints: IBS symptom severity, Stool frequency and 1 more. Started Jan 2020; status: completed.
02
Drugs
glutamine
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ISRCTN85973621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85973621.